Starpharma Holdings Limited (ASX:SPL)
Australia flag Australia · Delayed Price · Currency is AUD
0.7300
-0.0300 (-3.95%)
Aug 21, 2026, 4:10 PM AEST

Starpharma Holdings Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
3483739127302607
Market Cap Growth
540.53%-5.98%-69.24%-57.90%-50.21%44.84%
Enterprise Value
331191091255538
Last Close Price
0.730.090.090.300.721.46

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Forward PE
-34.9434.9434.9434.9434.94
PS Ratio
23.896.294.0129.3058.55174.10
PB Ratio
16.211.941.393.666.259.74
P/TBV Ratio
16.211.941.393.666.259.74

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
22.693.251.0420.9749.34154.38

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
0.040.130.130.240.170.02
Net Debt / Equity Ratio
-0.81-0.68-0.70-0.77-0.86-0.95
Net Debt / EBITDA Ratio
5.891.342.531.772.643.05
Net Debt / FCF Ratio
15.871.912.811.802.983.94
Asset Turnover
0.520.190.220.070.070.06
Inventory Turnover
4.954.434.134.426.3614.33
Quick Ratio
4.863.764.463.005.656.61
Current Ratio
5.264.324.943.265.936.78
Return on Equity (ROE)
-14.47%-42.41%-25.95%-37.59%-29.19%-42.15%
Return on Assets (ROA)
-7.24%-20.06%-11.48%-16.53%-14.48%-21.96%
Return on Capital Employed (ROCE)
-15.00%-49.50%-27.10%-41.60%-28.90%-31.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-0.93%-27.14%-20.86%-12.29%-5.34%-3.25%
FCF Yield
-0.32%-18.48%-18.05%-11.73%-4.63%-2.48%
Buyback Yield / Dilution
-1.07%-1.40%-0.59%-0.53%-2.53%-6.62%